Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
MYGN
MYGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest MYGN ETF News Today | Earnings, Events & Price Alerts
MYGN News
AMD Partners with Meta for GPU Supply Deal
Feb 24 2026
CNBC
Keysight Technologies Quarterly Earnings Beat Estimates
Feb 24 2026
Benzinga
Myriad Genetics Surges 24% After Earnings Beat and 2026 Revenue Target of $860M-$880M
Feb 24 2026
seekingalpha
Myriad Genetics Reports Strong Q4 2025 Earnings and Growth Outlook
Feb 24 2026
seekingalpha
Myriad Genetics (MYGN) Q4 2025 Earnings Transcript
Feb 24 2026
NASDAQ.COM
Myriad Genetics Q4 Earnings Exceed Expectations
Feb 23 2026
seekingalpha
Myriad Genetics to Announce Q4 Earnings on February 23
Feb 20 2026
seekingalpha
Myriad Genetics Publishes Validation of FirstGene Prenatal Screening
Feb 19 2026
Newsfilter
Myriad Genetics Schedules Q4 and Full Year 2025 Earnings Call
Feb 16 2026
Newsfilter
Myriad Genetics Unveils Commercialization Roadmap for Precise MRD Assay
Jan 27 2026
NASDAQ.COM
Myriad Genetics (MYGN) Projects Q4 Revenue of $207M-$209M
Jan 12 2026
NASDAQ.COM
Myriad Genetics CEO Sam Raha to Present at J.P. Morgan Healthcare Conference on Jan 14
Jan 05 2026
Globenewswire
Myriad Genetics Presents Eight Breast Cancer Research Abstracts at SABCS 2025
Dec 09 2025
Newsfilter
Market Update: Health Care Stocks Rise in Premarket Trading on Wednesday
Nov 26 2025
Yahoo Finance
Clairity and Myriad Collaborate to Enhance Breast Cancer Risk Assessment
Nov 25 2025
Newsfilter
What Factors Contributed to Tempus AI Achieving Positive EBITDA in Q3?
Nov 17 2025
NASDAQ.COM
Show More News
